What happened to the FDA’s toughest regulator?

Off Biotech, Congress, D.C. Diagnosis, dementia, drug pricing, FDA, Human Health, Joe Biden, Life Sciences, Medicine, newsletter-dcd, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Why Billy Dunn’s support of Aduhelm is so shocking

Read the rest…

Read Original Article: What happened to the FDA’s toughest regulator? »

About The Author